Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Azacitidine
Related studies linked through entity extraction aliases.
Phase I Dose Escalation Trial of Volasertib in Combination With Azacitidine in Patients With MDS or CMML
- Status
- TERMINATED
- Phase
- PHASE1
Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Anti-PD1 Epigenetic Therapy Study in NSCLC.
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Part 2 Expansion of Oral Rigosertib in Combination With Azacitidine
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Vosaroxin and Azacitidine in Treating Patients With Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
Quizartinib With Azacitidine or Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery
- Status
- TERMINATED
- Phase
- PHASE1
Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Study of MLN4924 Plus Azacitidine in Treatment-naive Participants With Acute Myelogenous Leukemia (AML) Who Are 60 Years or Older
- Status
- COMPLETED
- Phase
- PHASE1
Azacitidine Compared to Conventional Chemotherapy as Consolidation of Elderly Patients With AML
- Status
- TERMINATED
- Phase
- PHASE2
Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- Status
- COMPLETED
- Phase
- PHASE2
Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Decitabine Versus Azacitidine in Myelodysplastic Syndrome Patients With Low and Intermediate-1 Risk
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS
- Status
- COMPLETED
- Phase
- PHASE2
5 Day Versus 7 Day Azacitidine in Lower Risk Myelodysplastic Syndrome
- Status
- UNKNOWN
- Phase
- PHASE2